Profile
Full Name
Xilio Therapeutics, Inc.Ticker Symbol
XLOExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
October 22, 2021Indexes
Not includedWebsite
http://xiliotx.comEmployees
64Key Details
Price
$0.71(+7.10%)
Market cap
$36.71M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$6.34M
Annual EPS
-$1.09(+60.79% YoY)
PE ratio
-
Next earnings date
May 14, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Xilio Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Nov 8, 24 Raymond James
OutperformMay 30, 23 Chardan Capital
BuyMay 11, 23 Chardan Capital
BuyJan 27, 23 Morgan Stanley
OverweightDec 21, 22 Chardan Capital
BuyNov 10, 22 Raymond James
OutperformAug 10, 22 Morgan Stanley
OverweightJan 10, 22 HC Wainwright & Co.
BuyNov 16, 21 Raymond James
OutperformNov 16, 21 Morgan Stanley
OverweightInstitutional Ownership
- What is the ticker symbol for Xilio Therapeutics?
- Does Xilio Therapeutics pay dividends?
- What sector is Xilio Therapeutics in?
- What industry is Xilio Therapeutics in?
- What country is Xilio Therapeutics based in?
- When did Xilio Therapeutics go public?
- Is Xilio Therapeutics in the S&P 500?
- Is Xilio Therapeutics in the NASDAQ 100?
- Is Xilio Therapeutics in the Dow Jones?
- When was Xilio Therapeutics's last earnings report?
- When does Xilio Therapeutics report earnings?
- Should I buy Xilio Therapeutics stock now?
What is the ticker symbol for Xilio Therapeutics?
The ticker symbol for Xilio Therapeutics is NASDAQ:XLO
Does Xilio Therapeutics pay dividends?
No, Xilio Therapeutics does not pay dividends
What sector is Xilio Therapeutics in?
Xilio Therapeutics is in the Healthcare sector
What industry is Xilio Therapeutics in?
Xilio Therapeutics is in the Biotechnology industry
What country is Xilio Therapeutics based in?
Xilio Therapeutics is headquartered in United States
When did Xilio Therapeutics go public?
Xilio Therapeutics's initial public offering (IPO) was on October 22, 2021
Is Xilio Therapeutics in the S&P 500?
No, Xilio Therapeutics is not included in the S&P 500 index
Is Xilio Therapeutics in the NASDAQ 100?
No, Xilio Therapeutics is not included in the NASDAQ 100 index
Is Xilio Therapeutics in the Dow Jones?
No, Xilio Therapeutics is not included in the Dow Jones index
When was Xilio Therapeutics's last earnings report?
Xilio Therapeutics's most recent earnings report was on Mar 11, 2025
When does Xilio Therapeutics report earnings?
The next expected earnings date for Xilio Therapeutics is May 14, 2025
Should I buy Xilio Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions